MEMANTINE HYDROCHLORIDE | A206032 | RISING PHARMA HOLDING INC
Highest NADAC/Unit
$0.3537
per ea
Lowest NADAC/Unit
$0.3073
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16571085403MEMANTINE HCL ER 21 MG CAPSULE | $0.3537 | EA | Generic | — | 2026-10-21 |
| 16571085303MEMANTINE HCL ER 14 MG CAPSULE | $0.3435 | EA | Generic | — | 2026-10-21 |
| 16571085309MEMANTINE HCL ER 14 MG CAPSULE | $0.3435 | EA | Generic | — | 2026-10-21 |
| 16571085503MEMANTINE HCL ER 28 MG CAPSULE | $0.3252 | EA | Generic | — | 2026-10-21 |
| 16571085509MEMANTINE HCL ER 28 MG CAPSULE | $0.3252 | EA | Generic | — | 2026-10-21 |
| 16571085203MEMANTINE HCL ER 7 MG CAPSULE | $0.3073 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.